PROCTER & GAMBLE HEALTH | SANOFI INDIA | PROCTER & GAMBLE HEALTH/ SANOFI INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 31.6 | 109.4% | View Chart |
P/BV | x | 10.6 | 20.1 | 52.4% | View Chart |
Dividend Yield | % | 2.0 | 2.0 | 99.7% |
PROCTER & GAMBLE HEALTH SANOFI INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SANOFI INDIA Dec-23 |
PROCTER & GAMBLE HEALTH/ SANOFI INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 8,278 | 64.8% | |
Low | Rs | 3,883 | 5,240 | 74.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 1,238.0 | 59.8% | |
Earnings per share (Unadj.) | Rs | 138.2 | 261.8 | 52.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 279.0 | 55.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 167.00 | 56.9% | |
Avg Dividend yield | % | 2.1 | 2.5 | 83.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 411.2 | 108.9% | |
Shares outstanding (eoy) | m | 16.60 | 23.03 | 72.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.5 | 114.3% | |
Avg P/E ratio | x | 33.5 | 25.8 | 129.6% | |
P/CF ratio (eoy) | x | 29.8 | 24.2 | 123.0% | |
Price / Book Value ratio | x | 10.3 | 16.4 | 62.8% | |
Dividend payout | % | 68.7 | 63.8 | 107.7% | |
Avg Mkt Cap | Rs m | 76,761 | 155,659 | 49.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 3,706 | 55.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 28,511 | 43.1% | |
Other income | Rs m | 184 | 665 | 27.7% | |
Total revenues | Rs m | 12,480 | 29,176 | 42.8% | |
Gross profit | Rs m | 3,247 | 8,203 | 39.6% | |
Depreciation | Rs m | 281 | 396 | 71.0% | |
Interest | Rs m | 8 | 17 | 45.3% | |
Profit before tax | Rs m | 3,142 | 8,455 | 37.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2,426 | 34.9% | |
Profit after tax | Rs m | 2,295 | 6,029 | 38.1% | |
Gross profit margin | % | 26.4 | 28.8 | 91.8% | |
Effective tax rate | % | 27.0 | 28.7 | 94.0% | |
Net profit margin | % | 18.7 | 21.1 | 88.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 31,314 | 37.4% | |
Current liabilities | Rs m | 6,791 | 25,347 | 26.8% | |
Net working cap to sales | % | 40.0 | 20.9 | 191.3% | |
Current ratio | x | 1.7 | 1.2 | 139.6% | |
Inventory Days | Days | 263 | 159 | 165.4% | |
Debtors Days | Days | 343 | 17 | 2,037.2% | |
Net fixed assets | Rs m | 10,617 | 15,714 | 67.6% | |
Share capital | Rs m | 166 | 230 | 72.2% | |
"Free" reserves | Rs m | 7,265 | 9,239 | 78.6% | |
Net worth | Rs m | 7,431 | 9,469 | 78.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 47,028 | 47.5% | |
Interest coverage | x | 409.1 | 498.4 | 82.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 90.8% | |
Return on assets | % | 10.3 | 12.9 | 80.2% | |
Return on equity | % | 30.9 | 63.7 | 48.5% | |
Return on capital | % | 42.4 | 89.5 | 47.4% | |
Exports to sales | % | 0 | 18.0 | 0.0% | |
Imports to sales | % | 13.1 | 25.2 | 51.9% | |
Exports (fob) | Rs m | NA | 5,143 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 7,177 | 22.4% | |
Fx inflow | Rs m | 1,465 | 5,143 | 28.5% | |
Fx outflow | Rs m | 1,605 | 7,177 | 22.4% | |
Net fx | Rs m | -140 | -2,034 | 6.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2,304 | 102.4% | |
From Investments | Rs m | -215 | 375 | -57.3% | |
From Financial Activity | Rs m | -985 | -8,783 | 11.2% | |
Net Cashflow | Rs m | 1,160 | -6,104 | -19.0% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 60.4 | 85.8% | |
Indian inst/Mut Fund | % | 20.0 | 29.0 | 68.9% | |
FIIs | % | 6.2 | 6.1 | 102.1% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 39.6 | 121.7% | |
Shareholders | 56,778 | 61,849 | 91.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Sanofi India | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.76% | 0.45% |
1-Month | -1.15% | 7.36% | 2.55% |
1-Year | 0.73% | 38.51% | 56.14% |
3-Year CAGR | -8.76% | 3.63% | 15.22% |
5-Year CAGR | 4.97% | 8.02% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Sanofi India share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Sanofi India the stake stands at 60.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Sanofi India.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Sanofi India paid Rs 167.0, and its dividend payout ratio stood at 63.8%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Sanofi India.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.